文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气复苏、休克与脓毒症

人工气道患者碳青霉烯耐药肺炎克雷伯菌感染相关因素分析

[Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论ICU人工气道机械通气患者中,COPD、严重低蛋白血症、机械通气>10天及检出肺炎克雷伯菌前使用碳青霉烯类抗生素是CRKP感染的独立危险因素。

该回顾性研究纳入2016年1月至2019年12月北京世纪坛医院ICU的肺炎克雷伯菌肺炎患者,比较CRKP组(288例)与CSKP组(78例)的临床特征及耐药基因。CRKP组年龄更大、APACHE II更高、机械通气>10天比例63.2% vs 12.8%、检出前使用碳青霉烯类79.86% vs 41.03%、28天死亡率21.5% vs 10.3%。多因素Logistic回归显示COPD、严重低蛋白血症、机械通气>10天、检出前使用碳青霉烯类是CRKP感染独立危险因素。提示缩短机械通气时间、避免非规范使用碳青霉烯类、提高血清白蛋白水平可能降低CRKP肺炎发生率。

要点

  • 机械通气>10天者CRKP比例63.2%(182/288)vs CSKP 12.8%(10/78),是独立危险因素,应每日评估脱机。
  • 检出肺炎克雷伯菌前使用碳青霉烯类者CRKP占79.86%(230/288)vs 41.03%(32/78),为独立危险因素,应严格把控碳青霉烯类指征。
  • COPD(35.76% vs 11.54%)和严重低蛋白血症(白蛋白24.1 vs 30.1 g/L)为独立危险因素,需关注营养与白蛋白水平。
  • CRKP组28天死亡率21.5%(62/288)vs 10.3%(8/78),APACHE II 25.00 vs 19.00,病情更重、预后更差。
  • CRKP耐药基因以TEM检出率最高(74.00%),qnrA最低(6.67%),另检出KPC、AmpC、AAC(3)-II、ant(3")-I、qnrS等。

适用人群与场景

  • ICU中人工气道并机械通气、发生肺炎克雷伯菌肺炎的患者;研究纳入2016年1月至2019年12月北京世纪坛医院ICU患者。
  • 排除人群原文未提及。

诊断标准与关键阈值

  • CRKP组为碳青霉烯耐药肺炎克雷伯菌肺炎患者(研究组,288例);对照组为碳青霉烯敏感肺炎克雷伯菌(CSKP)肺炎患者(78例)。
  • 严重低蛋白血症为多因素分析中的独立危险因素,原文未给出具体白蛋白界值。

处置流程与药物剂量

  • 原文建议缩短机械通气时间以降低CRKP肺炎发生率。
  • 原文建议避免碳青霉烯类抗生素的非规范使用。
  • 原文建议提高血清白蛋白水平以改善预后。
  • 具体药物剂量、给药途径及疗程原文未提及。

红旗征与不能漏的情况

  • 机械通气>10天、检出肺炎克雷伯菌前已使用碳青霉烯类或β-内酰胺酶抑制剂、使用超过两种抗生素,提示CRKP感染风险高。
  • 合并COPD、严重低蛋白血症、恶性肿瘤、肾功能衰竭、休克者CRKP比例更高,需警惕。
  • CRKP组28天死亡率21.5%(62/288),高于CSKP组10.3%(8/78),预后差需积极处理。

研究设计与关键结果

  • 研究类型为回顾性临床对照分析,单中心(北京世纪坛医院ICU),CRKP组288例、CSKP组78例。
  • CRKP组vs CSKP组:年龄81.5(72.0, 86.0)vs 78.0(71.0, 80.5)岁;APACHE II 25.00(20.00, 34.00)vs 19.00(14.00, 23.25)分;机械通气>10天63.2%(182/288)vs 12.8%(10/78);检出前使用β-内酰胺酶抑制剂75.69%(218/288)vs 30.77%(24/78);使用碳青霉烯类79.86%(230/288)vs 41.03
  • 多因素Logistic回归显示COPD、严重低蛋白血症、机械通气时间>10天、检出肺炎克雷伯菌前使用碳青霉烯类抗生素为CRKP感染独立危险因素。
  • 耐药率:研究组对头孢替坦、阿米卡星、哌拉西林/他唑巴坦、头孢他啶、头孢曲松、庆大霉素耐药率均显著高于对照组(82.99% vs 62.82%,49.31% vs 17.95%,75.69% vs 60.26%,81.25% vs 64.10%,80.21% vs 58.97%,91.32% vs 60.26%,均P<0.05)。
  • 2016至2019年肺炎克雷伯菌对氨曲南、哌拉西林/他唑巴坦、亚胺培南、环丙沙星耐药率差异有统计学意义(均P<0.05);氨曲南和哌拉西林/他唑巴坦耐药率2019年最高(88.17%和86.02%)、2016年最低(70.65%和57.61%);亚胺培南耐药率2018年最高(86.32%)、2016年最低(59.78%);环丙沙星耐药率2016年最高(76.09%)、2018年最低(53.68%)。
  • 基因检测:CRKP中检出TEM、KPC、AmpC、AAC(3)-II、ant(3")-I、qnrS等耐药基因,TEM检出率最高(74.00%),qnrA最低(6.67%)。

证据类型、等级与局限

  • 证据类型为单中心回顾性临床对照分析,非随机对照试验。
  • 局限:单中心、回顾性设计、样本量有限(CRKP组288例、CSKP组78例),原文未提及盲法或前瞻性验证。

对床旁实践的改变

  • 对ICU人工气道机械通气患者,应每日评估脱机可能、尽量缩短机械通气时间,以降低CRKP肺炎风险。
  • 检出肺炎克雷伯菌前应严格把控碳青霉烯类抗生素使用指征,避免非规范使用;对已使用碳青霉烯类者需警惕CRKP。
  • 合并COPD、严重低蛋白血症、长期卧床、休克、肾功能衰竭、恶性肿瘤者CRKP风险更高,经验性抗感染需覆盖耐药菌可能。
  • 原文建议提高血清白蛋白水平,但具体目标值及干预方式原文未提及,不能据此给出白蛋白输注阈值。

指南或共识出处

  • 原文未提及指南或共识名称;研究来源为北京世纪坛医院ICU 2016年1月至2019年12月临床数据。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the clinical characteristics and related influencing factors of carbapenem resistant Klebsiella pneumoniae (CRKP) in patients with artificial airway and mechanical ventilation in intensive care unit (ICU), and provide theoretical basis for clinical prevention of Klebsiella pneumoniae infection.

METHODS: The clinical data of patients with pulmonary infection of Klebsiella pneumoniae in ICU of Beijing Shijitan Hospital Affiliated to Capital Medical University from January 2016 to December 2019 were collected. Compared CRKP pneumonia patients (study group) with carbapenem antibiotic sensitive Klebsiella pneumoniae (CSKP) pneumonia patients (control group), the clinical characteristics [gender, age, acute physiology and chronic health evaluation II (APACHE II), duration of mechanical ventilation, proportion of patients with mechanical ventilation > 10 days, use of antibiotics before detection of Klebsiella pneumoniae, white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), albumin, bedridden for more than 1 month before admission, 28-day mortality] were analyzed. The drug resistance rates of Klebsiella pneumoniae in both groups and difference of drug resistance rate of Klebsiella pneumoniae to different antibiotics from 2016 to 2019 were compared. The risk factors of CRKP infection were analyzed by multivariate Logistic regression, and the related drug resistance genes were detected.

RESULTS: Compared with the control group, the study group was older [years old: 81.5 (72.0, 86.0) vs. 78.0 (71.0, 80.5)], APACHE II [point: 25.00 (20.00, 34.00) vs. 19.00 (14.00, 23.25)] and proportion of patients with mechanical ventilation > 10 days [63.2% (182/288) vs. 12.8% (10/78)], the use of β-lactamase inhibitor antibiotics before detection of Klebsiella pneumoniae [75.69% (218/288) vs. 30.77% (24/78)], the use of carbapenems [79.86% (230/288) vs. 41.03% (32/78)], the use of more than two kinds of antibiotics [80.90% (233/288) vs. 29.49% (23/78)], proportion of patients staying in bed for more than 1 month before admission [40.97% (118/288) vs. 11.54% (9/78)] and WBC [×109/L: 9.72 (6.41, 14.69) vs. 7.57 (5.84, 12.61)], CRP [mg/L: 74.45 (36.30, 158.88) vs. 39.22 (13.68, 92.51)], PCT [μg/L: 3.87 (0.82, 19.24) vs. 0.51 (0.25, 5.71)], 28-day mortality [21.5% (62/288) vs. 10.3% (8/78)] were higher, albumin [g/L: 24.1 (18.3, 28.6) vs. 30.1 (23.8, 35.1)] was lower, duration of mechanical ventilation [days: 16.5 (9.0, 19.0) vs. 7.0 (5.0, 10.0)] was longer, the proportion of patients with chronic obstructive pulmonary disease [COPD: 35.76% (103/288) vs. 11.54% (9/78)], malignant tumor [18.06% (52/288) vs. 5.13% (4/78)], renal failure [31.94% (92/288) vs. 11.54% (9/78)], shock [51.74% (149/288) vs. 19.23% (15/78)] were higher, and the differences were statistically significant (all P < 0.05). The drug resistance rates of Klebsiella pneumoniae to aztreonam, piperacillin/tazobactam, imipenem and ciprofloxacin were statistically significant (all P < 0.05); the drug resistance rates of Klebsiella pneumoniae to aztreonam and piperacillin/tazobactam were the highest in 2019 (88.17% and 86.02%, respectively), and the lowest in 2016 (70.65% and 57.61%, respectively). The drug resistance rate to imipenem was the highest in 2018 (86.32%), the lowest in 2016 (59.78%); the resistance rate to ciprofloxacin was the highest in 2016 (76.09%), and the lowest in 2018 (53.68%). The resistance rates of ceftetan, amikacin, piperacillin/tazobactam, ceftazidime, ceftriaxone and gentamicin in the study group were significantly higher than those in the control group (82.99% vs. 62.82%, 49.31% vs. 17.95%, 75.69% vs. 60.26%, 81.25% vs. 64.10%, 80.21% vs. 58.97%, 91.32% vs. 60.26%, all P < 0.05). Logistic regression analysis showed that COPD, severe hypoproteinemia, mechanical ventilation time > 10 days and the use of carbapenem antibiotics before detection of Klebsiella pneumoniae were independent risk factors of CRKP infection. Gene detection showed that there were TEM, KPC, AmpC, AAC(3)-II, ant(3")-I, qnrS and other drug resistance genes in CRKP. The detection rate of TEM was the highest (74.00%), and qnrA was the lowest (6.67%).

CONCLUSIONS: The occurrence of CRKP in ICU patients with artificial airway and mechanical ventilation is related to many factors. It is necessary to shorten the mechanical ventilation time, avoid the nonstandard use of carbapenem antibiotics, and improve the serum albumin level, so as to reduce the incidence of CRKP pneumonia and improve the prognosis of patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Bian W, Chen W, Gu X, et al. [Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33463491. doi:10.3760/cma.j.cn121430-20200601-00431

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。